Atlas Trials

Acquired Bleeding Disorder

26 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acquired Bleeding Disorder

RecordFirmDate
Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia (NCT01285089)Novo Nordisk A/S2010-12-01
Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers (NCT01153997)Novo Nordisk A/S2010-06-01
Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery (NCT00914589)Novo Nordisk A/S2009-07-01
Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany (NCT00697320)Novo Nordisk A/S2008-06-01
Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma (NCT00323570)Novo Nordisk A/S2006-05-01
Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects (NCT01561417)Novo Nordisk A/S2006-04-01
Factor VIIa in Acute Intracerebral Haemorrhage (NCT00266006)Novo Nordisk A/S2006-01-01
Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass (NCT02239146)Novo Nordisk A/S2005-10-01
Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding (NCT00184548)Novo Nordisk A/S2005-10-01
Recombinant Factor VIIa in Acute Intracerebral Haemorrhage (NCT00127283)Novo Nordisk A/S2005-05-01
Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury (NCT00123591)Novo Nordisk A/S2005-01-01
Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury (NCT00124293)Novo Nordisk A/S2004-10-06
Use of Activated Recombinant Human Factor VII in Cardiac Surgery (NCT00154427)Novo Nordisk A/S2004-08-01
Use of Activated Recombinant FVII in Spinal Surgery (NCT00102037)Novo Nordisk A/S2004-07-01
Use of NovoSeven® in Active Variceal Bleeding (NCT00154492)Novo Nordisk A/S2004-04-01
Recombinant Factor VIIa in Acute Intracerebral Haemorrhage (NCT00426803)Novo Nordisk A/S2002-08-01
Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation (NCT01564563)Novo Nordisk A/S2002-06-28
Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients (NCT01563523)Novo Nordisk A/S2002-03-01
Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease (NCT01562574)Novo Nordisk A/S2002-01-01
Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage (NCT01563445)Novo Nordisk A/S2001-11-01
Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation (NCT01563458)Novo Nordisk A/S2001-08-01
Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage (NCT01566786)Novo Nordisk A/S2001-08-01
Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy (NCT01562821)Novo Nordisk A/S2001-07-01
Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever (NCT01601613)Novo Nordisk A/S2001-07-01
Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation (NCT01562158)Novo Nordisk A/S2001-04-01

Track Acquired Bleeding Disorder automatically

Every clearance here is in the API, with alerts when new ones post.